Protagenic Therapeutics, Inc.

Ticker PTIX

Exchange OTC More
Industry Networking & Communication Devices More
Sector Technology More

1-10 Employees
Based in New York City, New York

Protagenic Therapeutics, Inc. (OTCQB: PTIX) is a pre-clinical biopharmaceutical company endeavoring to develop first-in-class neuro-active peptides into human therapeutics to treat anxiety, treatment-resistant depression, and other disorders.

Visit website

REPORT RATINGS

4.8 / 5.0 (136)

Protagenic Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 136 reviews.

Protagenic Therapeutics, Inc.

Most Recent Annual Report

MOST RECENT 2022 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Protagenic Therapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.